Literature DB >> 2777373

Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis.

R Ramphal1, N Houdret, L Koo, G Lamblin, P Roussel.   

Abstract

Pseudomonas aeruginosa is the most prominent colonizer of the respiratory tract of patients with cystic fibrosis, but it is not known why this occurs. P. aeruginosa adheres to mucins from normal individuals, but mucins from cystic fibrosis patients have not been studied. To compare adhesion to mucins from cystic fibrosis with other mucins, we prepared highly glycosylated mucin glycopeptides from cystic fibrosis and chronic bronchitis patients by ion-exchange and gel-filtration chromatography and measured the adhesion of P. aeruginosa 1244 to these glycopeptides. We found (i) that the most mucinlike glycopeptides from P. aeruginosa-infected cystic fibrosis sputa showed less bacterial adhesion than did the corresponding bronchitis samples, (ii) that the most adhesive activity in cystic fibrosis samples came from a fraction that contains O and N glycopeptides and may be in part a degradation product of P. aeruginosa infection, and (iii) that highly glycosylated glycopeptides of the most acidic species (sialylated and sulfated) showed no adhesion at all. A single cystic fibrosis sample not infected by P. aeruginosa showed better binding in the adhesion-positive fractions than did the infected sputa. These studies suggest that cystic fibrosis mucins may be altered after infection is established, resulting in less binding to some fragments. However, since the clinical picture shows heavy mucus colonization, other receptors, such as cellular glycolipids which have been shed into mucus, may be contributing to this colonization.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2777373      PMCID: PMC260771          DOI: 10.1128/iai.57.10.3066-3071.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Mucins from cystic fibrosis sputum.

Authors:  G Lamblin; J J Lafitte; M Lhermitte; P Degand; P Roussel
Journal:  Mod Probl Paediatr       Date:  1976 Oct 24-27

2.  Tracheobronchial mucus secretion in vivo and in vitro by epithelial tissues from cystic fibrosis and control subjects.

Authors:  T F Boat; P W Cheng; R E Wood
Journal:  Mod Probl Paediatr       Date:  1976 Oct 24-27

3.  Glycoprotein staining following electrophoresis on acrylamide gels.

Authors:  R M Zacharius; T E Zell; J H Morrison; J J Woodlock
Journal:  Anal Biochem       Date:  1969-07       Impact factor: 3.365

4.  Highly simplified analytical or preparative slab gel electrophoresis.

Authors:  J P Kerckaert
Journal:  Anal Biochem       Date:  1978-02       Impact factor: 3.365

5.  The use of the avidin-biotin complex as a tool in molecular biology.

Authors:  E A Bayer; M Wilchek
Journal:  Methods Biochem Anal       Date:  1980

6.  Antibacterial activity of bladder surface mucin duplicated by exogenous glycosaminoglycan (heparin).

Authors:  C L Parsons; S G Mulholland; H Anwar
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

7.  Structure determination of five sulfated oligosaccharides derived from tracheobronchial mucus glycoproteins.

Authors:  T P Mawhinney; E Adelstein; D A Morris; A M Mawhinney; G J Barbero
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

8.  Heterogeneity of the carbohydrate chains of sulfated bronchial glycoproteins isolated from a patient suffering from cystic fibrosis.

Authors:  P Roussel; G Lamblin; P Degand
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

9.  Chemical and physical properties of human bronchial mucus glycoproteins.

Authors:  G Lamblin; M Lhermitte; P Degand; P Roussel; H S Slayter
Journal:  Biochimie       Date:  1979       Impact factor: 4.079

10.  Extracellular neuraminidase production by a strain of Pseudomonas aeruginosa isolated from cystic fibrosis.

Authors:  R Leprat; Y Michel-Briand
Journal:  Ann Microbiol (Paris)       Date:  1980 Nov-Dec
View more
  15 in total

Review 1.  Recognition of mucin components by Pseudomonas aeruginosa.

Authors:  R Ramphal; S K Arora
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

2.  Changes in adherence of respiratory pathogens to HEp-2 cells induced by subinhibitory concentrations of sparfloxacin, ciprofloxacin, and trimethoprim.

Authors:  M R Visser; H Beumer; A I Hoepelman; M Rozenberg-Arska; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 3.  Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.

Authors:  G Lamblin; S Degroote; J M Perini; P Delmotte; A Scharfman; M Davril; J M Lo-Guidice; N Houdret; V Dumur; A Klein; P Rousse
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

4.  Human tracheobronchial mucin: purification and binding to Pseudomonas aeruginosa.

Authors:  M S Reddy
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

5.  Protection of human respiratory epithelium from Pseudomonas aeruginosa adherence by phosphatidylglycerol liposomes.

Authors:  S Girod de Bentzmann; O Bajolet-Laudinat; F Dupuit; D Pierrot; C Fuchey; M C Plotkowski; E Puchelle
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  In vitro binding of Helicobacter pylori to human gastric mucin.

Authors:  L S Tzouvelekis; A F Mentis; A M Makris; C Spiliadis; C Blackwell; D M Weir
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Modulation of Pseudomonas aeruginosa adherence to the corneal surface by mucus.

Authors:  S M Fleiszig; T S Zaidi; R Ramphal; G B Pier
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  A murine model of chronic mucosal colonization by Pseudomonas aeruginosa.

Authors:  G B Pier; G Meluleni; E Neuger
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

9.  Differences in the binding specificities of Pseudomonas aeruginosa M35 and Escherichia coli C600 for lipid-linked oligosaccharides with lactose-related core regions.

Authors:  I J Rosenstein; C T Yuen; M S Stoll; T Feizi
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

10.  Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.

Authors:  U Sajjan; J Reisman; P Doig; R T Irvin; G Forstner; J Forstner
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.